Skip to main content
    H

    Harrow Health Inc (HROW)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.09
    -1.03 (-3.42%)

    Market Cap: $1.13B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Harrow Health Inc (HROW) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Harrow Health (HROW) trades at 3.6x sales and 37.4x book value. Its P/S of 3.6x is below its 5-year median of 4.7x. Its forward P/E is 41.8x.

    Current Multiples

    Its enterprise value is 57.4x its EBITDA.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E41.8x
    Price to sales3.6x
    Price to book37.4x
    EV/EBITDA57.4x
    PEGN/A
    FCF yield-1.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 2.9% above 3.5x and its P/B is 157.9% above 14.5x.

    MultipleCurrent5-year median10-year median
    P/S3.6x4.7x3.5x
    P/B37.4x24.1x14.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 1.3x in 2017 to 6.6x in 2025. 2025 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$49.00107.1x6.6x34.3x
    2024$33.55N/A6.0x17.2x
    2023$11.20N/A2.8x5.6x
    2022$14.76N/A4.6x15.9x
    2021$8.64N/A3.2x21.0x
    2020$6.86N/A3.6x6.5x
    2019$7.78N/A3.9x7.3x
    2018$5.699.6x3.1x5.6x
    2017$1.70N/A1.3x13.6x
    2016$2.50N/A1.7x7.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HROW

    What is HROW's forward P/E ratio?

    Harrow Health has a forward P/E ratio of 41.8x.

    Is HROW stock overvalued?

    GNG's valuation label for HROW is Fairly valued.

    What is HROW's price to sales ratio?

    Harrow Health has a price to sales ratio of 3.6x.